Total Raised

$60.7M

Investors Count

13

Deal Terms

3

Funding, Valuation & Revenue

8 Fundings

Cepheid has raised $60.7M over 8 rounds.

Cepheid's latest funding round was a Grant for $28M on July 30, 2021.

Cepheid's valuation in November 2016 was $4,000M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/30/2021

Grant

$28M

U.S. Department of Health and Human Services

$XXM

0

FY undefined

1

11/5/2016

Acq - P2P

$4,000M

0

FY undefined

10

6/21/2000

IPO

$XXM

$XXM

0

FY undefined

10

1/6/2000

Series C

$XXM

$XXM

0

FY undefined

0

10/1/1998

Series A

$XXM

$XXM

0

FY undefined

0

Date

7/30/2021

11/5/2016

6/21/2000

1/6/2000

10/1/1998

Round

Grant

Acq - P2P

IPO

Series C

Series A

Amount

$28M

$XXM

$XXM

$XXM

Investors

U.S. Department of Health and Human Services

Valuation

$XXM

$4,000M

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

0

0

Start free trial
New call-to-action

Cepheid Deal Terms

3 Deal Terms

Cepheid's deal structure is available for 3 funding rounds, including their Acq - P2P from November 05, 2016.

Round

Acq - P2P

Series A

Series B

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acq - P2P

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

Cepheid Investors

13 Investors

Cepheid has 13 investors. U.S. Department of Health and Human Services invested in Cepheid's Grant funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/30/2021

7/30/2021

U.S. Department of Health and Human Services
1
Grant

Government

DC

11/5/2016

11/5/2016

1
Acq - P2P

Corporation

DC

4/13/1998

1/6/2000

2
Series B, Series C (2000)

Investment Bank

New York

00/00/0000

00/00/0000

Medtronic

Subscribe to see more

Corporation

Minnesota

00/00/0000

00/00/0000

R-H Capital Partners

Subscribe to see more

Investment Bank

Georgia

First funding

7/30/2021

11/5/2016

4/13/1998

00/00/0000

00/00/0000

Last Funding

7/30/2021

11/5/2016

1/6/2000

00/00/0000

00/00/0000

Investor

U.S. Department of Health and Human Services

Medtronic

R-H Capital Partners

Rounds

1
Grant
1
Acq - P2P
2
Series B, Series C (2000)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Government

Corporation

Investment Bank

Corporation

Investment Bank

Location

DC

DC

New York

Minnesota

Georgia

Cepheid Acquisitions

2 Acquisitions

Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/16/2021

Other

$XXM

$9.9M

Acquired

4

10/3/2014

Subscribe to see more

$XXM

Subscribe to see more

10

Date

12/16/2021

10/3/2014

Investment Stage

Other

Companies

Subscribe to see more

Valuation

$XXM

$XXM

Total Funding

$9.9M

Note

Acquired

Subscribe to see more

Sources

4

10

New call-to-action

Compare Cepheid to Competitors

Genalyte Logo
Genalyte

Genalyte is a tech-enabled laboratory that specializes in rapid onsite lab testing and automation within the healthcare sector. The laboratory offers comprehensive lab services with results in less than 30 minutes, utilizing a mobile laboratory platform and a central lab for tests that cannot be performed onsite. Genalyte primarily serves the healthcare industry with its College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified lab services, facilitated by its proprietary CloudLab telehealth platform and the Maverick platform for serological testing. It was founded in 2007 and is based in San Diego, California.

Biomeme Logo
Biomeme

Biomeme focuses on DNA diagnostics and disease surveillance in healthcare and research. The company provides a platform that allows smartphones to analyze and identify pathogens and diseases based on their DNA or RNA signatures. Biomeme serves the healthcare, agriculture, environmental, veterinary, and educational sectors with mobile testing solutions. It was founded in 2012 and is based in Philadelphia, Pennsylvania.

Ethicon Logo
Ethicon

Ethicon operating as a subsidiary of Johnson & Johnson, focuses on advancing surgical care. The company's main offerings include surgical technologies and solutions such as sutures, staplers, energy devices, and digital solutions. It aims to improve and save lives through innovative medical procedures. Ethicon primarily serves the healthcare industry. It was founded in 2010 and is based in Warsaw, Indiana.

Ascensia Diabetes Care Logo
Ascensia Diabetes Care

Ascensia Diabetes Care operates as a global company focused on diabetes care within the healthcare industry. The company offers a range of products including blood glucose monitoring systems and continuous glucose monitoring systems to help individuals with diabetes manage condition. It was founded in 2016 and is based in Basel, Switzerland.

Meridian Logo
Meridian

Meridian is a life science company involved in the development, manufacturing, marketing, and distribution of diagnostic test kits and reagents. The company provides diagnostic products that are used outside the human body with minimal equipment requirements for the diagnosis of medical conditions such as infections and lead poisoning. Meridian serves hospitals, reference laboratories, research centers, diagnostics manufacturers, and agri-bio companies globally. It was founded in 1977 and is based in Cincinnati, Ohio.

M
Meterbolic

Meterbolic conducts metabolic health assessments and preventive healthcare within the medical diagnostics sector. The company offers tests that measure insulin response and other metabolic markers to predict the risk of diabetes and other chronic diseases, which can assist in health management. Meterbolic serves individuals seeking health monitoring and those interested in preventive healthcare. It was founded in 2018 and is based in London, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.